US FDA Sees Leqembi Data As Vindicating Its Approach To Alzheimer’s Drugs

 
• By Brenda Sandburg
  
Alzheimer's puzzle
FDA touts confidence in connection between amyloid placque reduction and reduction in clinical decline • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers